Skip to main content
Erschienen in: Immunologic Research 6/2021

Open Access 15.09.2021 | Interpretive Synthesis Review Article

Tonsillectomy and the incidence of various types of cancer

verfasst von: Gábor Holló

Erschienen in: Immunologic Research | Ausgabe 6/2021

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

A potential connection between tonsillectomy and the development of various cancer types has repeatedly been reported in the scientific literature, but many studies have contradicted these observations. Thus, we have no clear evidence, neither to firmly support nor to refute the above-mentioned connection. Here, I suggest that the main reason for the lack of clearer evidence is that the investigations have so far mainly used incorrect sample groups. I propose that individual differences in the tonsils’ involvement in immune reactions should be taken into account to solve this long-standing puzzle.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The hypothesis that tonsillectomy increases the chance of tumour formation has been a regularly emerging theme in the medical literature for decades. It has been suggested that tonsillectomy could promote the emergence of various cancer types. It was found, for example, that tonsillectomy increased the liability to Hodgkin lymphoma [1], and the same conclusion has also been drawn by subsequent studies [2, 3]. A positive relationship between leukaemia and tonsillectomy was also observed in the early 70 s [4] and also repeatedly reported in later decades [5, 6]. An increasing effect of tonsillectomy on breast cancer risk with increasing age has also been shown [7]. It was proposed that tonsillectomy increased the risk of breast cancer in different target groups [8, 9]. It was also presented that a history of tonsillectomy correlated with a greater risk of prostate cancer [10]. A Taiwanese nationwide retrospective cohort study reported that a higher overall risk of all cancer types and a marginally significantly increased risk of breast cancer development was observed in tonsillectomised patients with more than 3 years of follow-up [11]. Tonsillectomy was also associated with heightened odds of developing base of tongue cancer [12].
However, other studies have reported results different from these. For example, it has been concluded that tonsillectomy did not affect carcinogenesis [13] and that there was no significant relationship between tonsillectomy and acute leukaemia [14]. Likewise, the frequency of tonsillectomy was shown to be greater in the control group than in the examined cancerous groups (e.g. [15]). It was also suggested that a higher proportion of tonsillectomy correlated with a decrease in Hodgkin lymphoma risk [16] and pancreatic cancer risk [17]. It was reported that tonsillectomy decreased the odds of tonsil cancer [12]. Some studies with small sample sizes found that the initial immunological deficit following tonsillectomy in children becomes normal after 1 month [18], 6 months [19], and 54 months [20]. Similarly, a recent study concluded that the examined humoral and cellular immunity markers were not altered by adenoidectomy with/without tonsillectomy in children, nor did the surgery lead to an increased risk of infection, nor to immune-deficiency disorders in the 3 months following the operation [21].
On the other hand, it has been emphasised that it was possible to develop cancer due to factors underlying tonsillectomy, such as tonsillitis, rather than to tonsillectomy itself [3]. Similarly, another study also pointed out that susceptibility to infections could explain both the formation of cancer and the necessity of the removal of the lymphatic tissue [5].
It is important to underline, however, that all the studies which were carried out on a considerably large sample (Ntot ≥ roughly 5000) reported some sort of positive relationship between tonsillectomy and cancer [2, 3, 10, 11].
On the basis of these results, the picture which emerges of the possible relationship between tonsillectomy and cancers is obscure and full of contradictions.
To explain this seemingly embarrassing pattern which unfolds from the literature, it may well be useful to take a closer look at the population samples and control groups used by the different studies. These groups vary on a broad spectrum, both in terms of number and composition; however, they share a common feature, namely that they do not take into account the potential individual differences regarding the involvement of the tonsils in immunity. As this argument has not still been investigated, it needs subpopulational analyses to determine how the presumptive differences manifest and to what extent.
It is a well-known phenomenon among otolaryngologists that the immunological functions of the tonsils are rich in childhood but decline as children become adults (e.g. [2225]). Perhaps the best sign of this is that the majority of children have large, hypertrophic tonsils, while only a minority of adults do. The tonsils are also subject to substantial age-related changes in their cellular composition [26]. Nevertheless, the immune functions of adult tonsils are also important and manifold [2729].
The role of the tonsils as secondary lymphoid organs in both humoral and cellular immunological processes has been known for a long time (e.g. [2225]). However, it is important to highlight that in the past decade, significant progress has been made regarding the functions of the tonsils in immunity. In addition to their traditionally known functions of harbouring and maturing lymphoid cells, it has become evident that the tonsils are also capable of generating a subset of these cells. For example, it has been reported that developing T cell precursors were detected extrathymically in the tonsils [30]: the tonsils actively produce T cells due to their comprehensive T cell development programme. In addition to producing and maturing T cells involved in adaptive immunity, the tonsils’ contribution to the development of another subset of immune cells with a potent anti-tumoral activity, the natural killer (NK) cells, which are part of innate immunity, has also received strong support [3133].
If T and NK cell development and maturation occurs in the tonsils, then tonsillectomy probably has consequences on T and NK cell functioning. Since both T cells and NK cells play an important role in the fight against tumours, tumorigenesis could logically—at least in certain cases and to a certain degree—be affected by the removal of the tonsils.
The tonsils may contribute to immune cell development differently in different people. Large tonsils in adulthood may be more immunologically functional than small tonsils. This notion is in line with a recent study conducted in children [34], although the phenomenon is far from being explored satisfactorily. However, as mentioned above, the hypertrophic tonsils may also be indicators of increased susceptibility to infections, and it could be these infections which may lead both to tonsillectomy and progress to various cancers [3, 5], especially when the tonsils are removed. In this regard, enlarged tonsils mas also indicate individuals fighting against more dangerous and potentially oncogenic infections, so the size of the tonsils could also simply reflect more dangerous and less dangerous infections. In summary, large tonsils could be indicative both of a greater threat from oncogenic pathogens, and of a high importance of the tonsils in immunologic activity.
Naturally, the degree of involvement of the tonsils in the immune responses may also not be connected to their size. Molecular and/or cellular markers are likely to be more reliable features in indicating their level of participation in immunity. Retinoic acid–inducible gene I (RIG-I), interferon alpha (IFN-α), mitochondrial antiviral-signaling protein (MAVS), NLR family pyrin domain containing 3 (NLRP3), toll-like receptor (TLR) 4 and TLR7, and several inflammatory markers (such as IL-1β, NF-κB, and IL-7) have been shown to be highly expressed in simple hypertrophic tonsils (i.e. not in hypertrophic tonsils with recurrent tonsillitis), showing the activity of pathogen-induced innate immune responses [34]. Likewise, neutrophil–lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) have been determined as indicators of systemic inflammation in adults [e.g. 35]. More specifically, the values of NLR [3537], PLR [36], and LMR [3840] have also been used for the prognosis of different types of cancer. However, the precise molecular and/or cellular indicators of the tonsils’ immunologic activity are still to be determined.
From all this, it follows that childhood tonsillectomy will probably negatively affect those people who would have highly functional tonsils in adulthood, but not those whose tonsils would gradually lose their importance in immunity as the individual grows.
Thus, if the study samples examined were properly selected, a possible solution to the puzzle represented by tonsillectomy and its potential relation to cancer could be found. So far, both the tonsillectomised and the control groups of the studies cited have always also included individuals with presumably low functioning tonsils, which has probably biased the results by masking the pattern; i.e., it has shown tonsillectomy to be less harmful than it could be for sensitive people. On the one hand, the size of study samples may significantly influence the appearance of the real pattern: larger samples are expected to unveil it better [2, 3, 10, 11]. On the other hand, the composition of the samples is also important: tonsillectomy tends to be less likely in individuals with small tonsils, who may therefore be more heavily represented in the control group than in the tonsillectomy group.
A much more accurate procedure would be to look for adults with highly functional tonsils in the first place, to identify—if possible—molecular and/or cellular markers which differentiate them from those with low functioning tonsils, and to see whether the pattern holds when creating both the tonsillectomised group and the control group only from individuals with highly functioning tonsils who are potentially vulnerable to tonsillectomy. With the help of this approach, vulnerable children could also be identified, helping doctors in making decisions about childhood tonsillectomy.
Tonsillectomy has been reported to potentially cause serious—sometimes fatal—consequences (e.g. [4143]). In addition to this risk, the potentially impaired—or conversely, untouched—immune functions should also be considered while planning a personalised medical intervention to the tonsils.

Acknowledgements

I thank Dr. Gergely Gábor Kiss for the early discussions on national cancer patterns, Dr. Attila Deák for discussions on otolaryngologic aspects, and Dr. Zsolt Kanyári for his help in initial data gathering. I am grateful to Dr. Gábor Hoffer for his criticism on the early draft of the paper, to Dr. Sándor Baráth for his valuable advice on immunologic aspects, and to George Seel for linguistic assistance.

Declarations

Conflict of interest

The author declares no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

Bis 11. April 2024 bestellen und im ersten Jahr 50 % sparen!

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

© Springer Medizin

Bis 11. April 2024 bestellen und im ersten Jahr 50 % sparen!

Literatur
7.
Zurück zum Zitat Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni JF Jr. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68:211–7.PubMed Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni JF Jr. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68:211–7.PubMed
8.
Zurück zum Zitat Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and “delayed” primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001;10:9–16.PubMed Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and “delayed” primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001;10:9–16.PubMed
10.
Zurück zum Zitat Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE. Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst. 1985;74:43–51.PubMed Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE. Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst. 1985;74:43–51.PubMed
22.
Zurück zum Zitat Brandtzaeg P. Immune functions and immunopathology of palatine and nasopharyngeal tonsils. In: Bernstein J, Ogra P, editors. Immunology of the ear. New York: Raven Press; 1987. p. 63–106. Brandtzaeg P. Immune functions and immunopathology of palatine and nasopharyngeal tonsils. In: Bernstein J, Ogra P, editors. Immunology of the ear. New York: Raven Press; 1987. p. 63–106.
23.
Zurück zum Zitat Andersson J, Abrams J, Björk L, Funa K, Litton M, Agren K, Andersson U. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology. 1994;83:16–24.PubMedPubMedCentral Andersson J, Abrams J, Björk L, Funa K, Litton M, Agren K, Andersson U. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology. 1994;83:16–24.PubMedPubMedCentral
24.
Zurück zum Zitat Bernstein JM, Gorfien J, Brandtzaeg P. The immunobiology of the tonsils and adenoids. In: Ogra P, editor. Mucosal immunology. San Diego: Academic Press; 1999. p. 1339–62. Bernstein JM, Gorfien J, Brandtzaeg P. The immunobiology of the tonsils and adenoids. In: Ogra P, editor. Mucosal immunology. San Diego: Academic Press; 1999. p. 1339–62.
Metadaten
Titel
Tonsillectomy and the incidence of various types of cancer
verfasst von
Gábor Holló
Publikationsdatum
15.09.2021
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 6/2021
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-021-09230-3

Weitere Artikel der Ausgabe 6/2021

Immunologic Research 6/2021 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.